Product
Alprazolam
Aliases
Alprazolam 2 mg, Oral alprazolam, Staccato alprazolam, UCB7538 (1 other aliases)
Name
ALPRAZOLAM
INN Name
alprazolam
FDA Approved
Yes
9 clinical trials
3 organizations
11 indications
2 documents
Indication
Healthy ParticipantsIndication
Abuse PotentialIndication
Stereotypical Prolonged SeizuresIndication
Healthy Control ParticipantsIndication
Healthy Study ParticipantsIndication
Mild AsthmaIndication
Opioid AbuseIndication
Benzodiazepine AbuseIndication
Polysubstance Use DisorderIndication
HealthyIndication
Food-drug InteractionClinical trial
An Open-Label, Randomized, Single-Dose, 2-Way Crossover Study to Evaluate The Relative Bioavailability of Staccato Alprazolam Compared to Oral Alprazolam in Healthy Study ParticipantsStatus: Completed, Estimated PCD: 2023-02-24
Clinical trial
A Randomized, Double Blind, Active and Placebo Controlled, 5 Way Crossover Study to Determine the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules in Healthy, Nondependent Recreational Drug Users With Sedative ExperienceStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresStatus: , Estimated PCD: 2026-05-22
Clinical trial
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresStatus: Recruiting, Estimated PCD: 2024-04-17
Clinical trial
A Phase 1, Randomized, Double-Blind, Double-Dummy, Active- and Placebo-Controlled, 5-Way Crossover Study Evaluating the Abuse Potential of Soticlestat (TAK-935) in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System Depressant ExperienceStatus: Completed, Estimated PCD: 2023-06-29
Clinical trial
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover (Part A) and 2-Arm Parallel Group (Part B) Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants (Part A) and in Study Participants With Mild Asthma (Part B)Status: Completed, Estimated PCD: 2021-11-22
Clinical trial
Opioid/Benzodiazepine Polydrug Abuse: Integrating Research on Mechanisms, Treatment and Policies - Study 3Status: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Single-Dose Fasting In Vivo Bioequivalence Study of Alprazolam Extended-Release Tablets (1 mg; Mylan) to Xanax XR Tablets (1 mg; Pharmacia & Upjohn) in Healthy VolunteersStatus: Completed, Estimated PCD: 2005-01-01
Clinical trial
Licorice Botanical Dietary Supplements - Metabolism and Safety in WomenStatus: Completed, Estimated PCD: 2020-07-31
Document
DailyMed Label: ALPRAZOLAMOrganization
STAT RX USA LLCDocument
DailyMed Label: XanaxOrganization
Pharmacia & Upjohn Company LLCOrganization
Viatris Specialty LLC